Beacon Biomedical

Beacon Biomedical is a specialty diagnostic company headquartered in Scottsdale, Arizona, dedicated to the development and commercialization of high-performance, blood-based cancer screening tests. The company's flagship product, BeScreened-CRC, is a proteomic-based assay designed for the early detection of colorectal cancer, offering a patient-friendly alternative to invasive colonoscopies or stool-based testing. By identifying specific protein biomarkers associated with the presence of colorectal neoplasia, the test aims to increase screening compliance and facilitate earlier intervention. Beyond colorectal cancer, Beacon Biomedical is leveraging its proteomic platform to develop similar screening solutions for breast and lung cancers. The company operates primarily through partnerships and CLIA-certified laboratory environments to bring its diagnostic innovations to the clinical market.